Association of macular outward scleral height with axial length, macular choroidal thickness and morphologic characteristics of the optic disc in Chinese adults

© 2023. The Author(s), under exclusive licence to The Royal College of Ophthalmologists..

PURPOSE: To identify the relationship of macular outward scleral height (MOSH) with axial length (AL), macular choroidal thickness (ChT), peripapillary atrophy (PPA), and optic disc tilt in Chinese adults.

METHODS: In this cross-sectional study, 1088 right eyes of 1088 participants were enrolled and assigned into high myopia (HM) and non-HM groups. MOSH was measured in the nasal, temporal, superior, and inferior directions using swept-source optical coherence tomography images. The clinical characteristics of MOSH and the association of MOSH with AL, macular ChT, PPA, and tilt ratio were analysed.

RESULTS: The mean age of participants was 37.31 ± 18.93 years (range, 18-86 years), and the mean AL was 25.78 ± 1.79 mm (range, 21.25-33.09 mm). MOSH was the highest in the temporal direction, followed by the superior, nasal, and inferior directions (all p < 0.001). The MOSH of HM eyes was significantly higher than that of non-HM eyes, and it was positively correlated with AL in the nasal, temporal, and superior directions (all p < 0.001). Macular ChT was independently associated with the average MOSH (B = -0.190, p < 0.001). Nasal MOSH was positively associated with the PPA area and the presence of a tilted optic disc (both p < 0.01). Eyes with a higher MOSH in the superior (odds ratio [OR] = 1.008; p < 0.001) and inferior directions (OR = 1.006; p = 0.009) were more likely to have posterior staphyloma.

CONCLUSION: MOSH is an early indicator of scleral deformation, and it is correlated positively with AL and negatively with ChT. A higher nasal MOSH is associated with a larger PPA area and the presence of a tilted optic disc. Higher MOSH values in the superior and inferior directions were risk factors for posterior staphyloma.

CLINICAL TRIAL REGISTRATION: The study was registered at www.

CLINICALTRIALS: gov (Reg. No. NCT03446300).

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:38

Enthalten in:

Eye (London, England) - 38(2024), 5 vom: 19. Apr., Seite 923-929

Sprache:

Englisch

Beteiligte Personen:

Li, Menghan [VerfasserIn]
Xu, Hannan [VerfasserIn]
Ye, Luyao [VerfasserIn]
Zhou, Siheng [VerfasserIn]
Xie, Jiamin [VerfasserIn]
Liu, Chen [VerfasserIn]
Zhu, Jianfeng [VerfasserIn]
He, Jiangnan [VerfasserIn]
Fan, Ying [VerfasserIn]
Xu, Xun [VerfasserIn]

Links:

Volltext

Themen:

Clinical Trial
Journal Article

Anmerkungen:

Date Completed 28.03.2024

Date Revised 04.04.2024

published: Print-Electronic

ClinicalTrials.gov: NCT03446300

Citation Status MEDLINE

doi:

10.1038/s41433-023-02804-5

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM363907289